Corvus Pharmaceuticals Inc

CRVS NASDAQ Healthcare & Biotech United States US2210151005
9.83 $
1.34 %

Corvus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of immuno-oncology treatments.